Pharma-Bio Serv, Inc. financial data

Symbol
PBSV on OTC
Location
Dorado, PR
Fiscal year end
31 October
Latest financial report
10-K - Q3 2025 - 29 Jan 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 645% % -6.8%
Debt-to-equity 19% % -19%
Return On Equity -0.84% % 85%
Return On Assets -0.7% % 84%
Operating Margin -7.1% % 48%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 22,904,492 shares -0.23%
Common Stock, Shares, Outstanding 22,905,992 shares -0.23%
Entity Public Float $6,136,220 USD -55%
Common Stock, Value, Issued $2,352 USD 0%
Weighted Average Number of Shares Outstanding, Basic 22,947,243 shares -0.08%
Weighted Average Number of Shares Outstanding, Diluted 22,956,853 shares -0.08%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $9,001,096 USD -5.3%
Cost of Revenue $6,091,064 USD -13%
Operating Income (Loss) $637,662 USD 50%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $94,260 USD 88%
Income Tax Expense (Benefit) $6,203 USD -72%
Net Income (Loss) Attributable to Parent $100,463 USD 87%
Earnings Per Share, Diluted -0.01 USD/shares 75%

Balance Sheet

Label TTM Value / Value Unit Change %
Marketable Securities, Current $7,475,377 USD 25%
Accounts Receivable, after Allowance for Credit Loss, Current $2,360,682 USD -6%
Assets, Current $13,386,845 USD -15%
Property, Plant and Equipment, Net $116,059 USD -31%
Operating Lease, Right-of-Use Asset $29,388 USD -85%
Other Assets, Noncurrent $120,754 USD -46%
Assets $13,653,046 USD -16%
Liabilities, Current $1,738,799 USD -7.9%
Accrued Income Taxes, Noncurrent $0 USD
Operating Lease, Liability, Noncurrent $0 USD -100%
Liabilities $1,738,799 USD -33%
Accumulated Other Comprehensive Income (Loss), Net of Tax $278,045 USD 6%
Retained Earnings (Accumulated Deficit) $10,533,589 USD -15%
Stockholders' Equity Attributable to Parent $11,914,247 USD -13%
Liabilities and Equity $13,653,046 USD -16%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $214,886 USD 62%
Net Cash Provided by (Used in) Financing Activities $1,751,361 USD -1%
Net Cash Provided by (Used in) Investing Activities $1,466,391 USD -7.8%
Common Stock, Shares Authorized 50,000,000 shares 0%
Common Stock, Shares, Issued 23,519,672 shares 0%
Common Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $3,388,144 USD 7.9%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $3,379,212 USD -50%
Interest Paid, Excluding Capitalized Interest, Operating Activities $0 USD
Operating Lease, Liability $194,035 USD -44%
Payments to Acquire Property, Plant, and Equipment $6,644 USD -96%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $84,798 USD 88%
Lessee, Operating Lease, Liability, to be Paid $29,122 USD
Property, Plant and Equipment, Gross $315,988 USD -62%
Operating Lease, Liability, Current $28,834 USD -83%
Lessee, Operating Lease, Liability, to be Paid, Year Two $29,121 USD -83%
Lessee, Operating Lease, Liability, to be Paid, Year One $174,730 USD 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $9,816 USD -69%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Additional Paid in Capital $1,679,547 USD 2.1%
Preferred Stock, Shares Outstanding 0 shares
Preferred Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%